When SMAD4 is loss-of-function mutant, ASCL1 transcription is activated by MYC/MAX complex, which will further regulate neuroendocrine phenotype in NSCLC (Fig. 4H). This evidence concerns the gene MYC and non-small cell lung carcinoma.